Replay available

Indutrade AB (publ) (INDT) Q2 2026 Earnings Call

Indutrade AB (publ) (STO: INDT) Q2 2026 earnings conference call, held 2026-07-16. Replay captured from the company's public earnings webcast.

Thu, July 16, 2026 at 3:30 AMendedReplay
Indutrade AB (publ) (INDT) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Patrik Johnson

CFO

Bo Anvik

CEO

Carl Boakvist

Analyst, ABG Sundahl Collier

Johan Lankvist Sundhien

Analyst, DNB Carnegie

Zeno Englund Rick Tjudi

Analyst, Handelsbanken

Gustav Bernebled

Analyst, Nordia

Op Otani

Analyst, Goldman Sachs

Max Bako

Analyst, SEB

Replay transcript excerpt

Welcome to the Indutrade Q2 presentation for 2026. During the questions and answers session, participants are able to ask questions by dialing pound key five on their telephone keypad. Now I will hand the conference over to CEO Bo Anvik and CFO Patrik Johnson. Please go ahead. Welcome and good morning on our behalf as well. We are glad to present a strong quarter and let's start with the overall highlights. We had a good development in many areas in the quarter, starting with the top-line development. Demand continued to improve and total order growth was 14%, of which 8% organically, with the majority of our companies growing. Continued positive book-to-bill of 105%. And the strongest demand was with companies having customers within the medtech and pharma area and also the energy sector. Net sales increased 11% in total to record high 9 billion SEK with strong organic growth of 5%. EBITDA was also on a record high level and EBITDA margin improved to 14.7% with good operational leverage on the organic sales and margin accretive acquisitions. Cash flow from operating activities increased and inventory levels were flat from last year organically. We continued being successful in terms of acquisitions. Nine companies acquired in 2026 so far and slightly larger companies on average. Our pipeline remains strong. As mentioned, top line development was strong and demand improved. However, still varies across companies, geographies and segments. Companies with customers within medtech and pharma and the energy sector experienced the strongest demand, but all major customer segments improved compared to last year. Despite the strong net sales, order intake was even higher, resulting in a positive book to build in the quarter. The order backlog is now 8% higher than the same ...

More from Indutrade Ab